Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Common Equity (2016 - 2025)

Historic Common Equity for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $349.2 million.

  • Healthstream's Common Equity fell 176.89% to $349.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.2 million, marking a year-over-year decrease of 176.89%. This contributed to the annual value of $359.4 million for FY2024, which is 545.94% up from last year.
  • Healthstream's Common Equity amounted to $349.2 million in Q3 2025, which was down 176.89% from $350.6 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Common Equity registered a high of $362.8 million during Q1 2025, and its lowest value of $322.6 million during Q1 2022.
  • In the last 5 years, Healthstream's Common Equity had a median value of $340.8 million in 2023 and averaged $342.3 million.
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 422.59% in 2022, then surged by 545.94% in 2024.
  • Healthstream's Common Equity (Quarter) stood at $339.0 million in 2021, then decreased by 1.46% to $334.1 million in 2022, then rose by 2.0% to $340.8 million in 2023, then rose by 5.46% to $359.4 million in 2024, then fell by 2.83% to $349.2 million in 2025.
  • Its last three reported values are $349.2 million in Q3 2025, $350.6 million for Q2 2025, and $362.8 million during Q1 2025.